Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2010
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137317 1,2-Disubstituted Heterocyclic Compounds
06/03/2010US20100137316 Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof
06/03/2010US20100137313 Heterocyclic derivatives and methods of use thereof
06/03/2010US20100137312 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
06/03/2010US20100137311 Substituted pyrimidine derivatives
06/03/2010US20100137310 Renin inhibitors
06/03/2010US20100137309 Fungicides phenyl-pyrimidnyl-amino derivatives
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137307 Novel 1,2,3,4,-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced terein and has glucocorticoid receptor-binding activity
06/03/2010US20100137306 Heterocyclic trpv1 receptor ligands
06/03/2010US20100137305 Aminopyrimidines useful as kinase inhibitors
06/03/2010US20100137304 Novel crystalline forms of the anti-cancer compound zd1839
06/03/2010US20100137300 Indolizine Acetic Acid Derivatives as CRTH2 Antagonists
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137290 Oxazolidinone antibiotic derivatives
06/03/2010US20100137282 Tricyclic nitrogen containing compounds as antibacterial agents
06/03/2010US20100137280 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
06/03/2010US20100137278 Pyrazine compounds as phosphodiesterase 10 inhibitors
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/03/2010US20100137243 Oxazolidinone And/Or Isoxazoline As Antibacterial Agents
06/03/2010US20100136136 JAK-2 Modulators and Methods of Use
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100135960 Antiviral acylsulfonamide derivatives
06/03/2010US20100135954 6-Phenylpyrimidinones as PIM Modulators
06/03/2010US20100132856 Furazane derivatives, preparation thereof and energetic compositions containing them
06/03/2010CA2745004A1 Pyridine-3-carboxyamide derivative
06/03/2010CA2742463A1 3-(benzylamin0)-pyrr0lidine derivatives and their use as nk-3 receptor antagonists
06/02/2010EP2192116A1 Indazole acrylic acid amide compound
06/02/2010EP2190852A1 Bicyclic sphingosine 1-phosphate analogs
06/02/2010EP2190841A1 Substituted oxazolidinone derivatives
06/02/2010EP2190840A2 Chemical compounds 979
06/02/2010EP2190835A1 Adrenergic compounds
06/02/2010EP2190826A2 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
06/02/2010EP2190825A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
06/02/2010EP2190290A2 Method and means relating to multiple herbicide resistance in plants
06/02/2010EP2049532B1 Cgrp receptor antagonists
06/02/2010EP2001478B1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
06/02/2010EP1890672B1 Use of chromone derivatives
06/02/2010EP1745040B9 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
06/02/2010EP1417200B1 Substituted 1h-dihydropyrazoles, their preparation and use
06/02/2010EP1416797B1 Arthropodicidal anthranilamides
06/02/2010CN101720325A Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
06/01/2010US7728130 such as methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetate
06/01/2010US7728129 decarboxylation, amidation; industrial scale; for treatment of disorders and conditions mediated by histamine receptors; drug abuse, addiction; eating disorders; dementia
06/01/2010US7728029 hydroxysteroid reductase inhibitors such as 2'-tert-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid (5-hydroxy-adamantan-2-yl)-amide, used for the treatment of non-insulin dependent diabetes mellitus and metabolic syndrome
06/01/2010US7728025 Glucokinase activators as antidiabetic, antiobesity agents; 5-(4-methanesulfonyl-phenoxy)-2-pyrazin-2-yl-6-(2-carbamoyl-phenoxy)-1H-benzimidazole for example
06/01/2010US7728018 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonists
06/01/2010US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727989 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
06/01/2010US7727985 For therapy of inflammatory disease and cancer
06/01/2010US7727981 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
06/01/2010US7727716 Detection of immobilized nucleic acid
06/01/2010US7727511 Agents for imaging soluble a-beta
06/01/2010CA2515841C Novel 2-pyridine carboxamide derivatives
06/01/2010CA2438547C Isoxazoline derivative and herbicide containing the same as the active ingredient
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
05/2010
05/27/2010WO2010059658A1 Chemical compounds
05/27/2010WO2010059611A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059606A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059602A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059393A1 Serotonin receptor modulators
05/27/2010WO2010059241A2 Treatment of amyotrophic lateral sclerosis
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058423A2 Novel antimicrobials
05/27/2010WO2010058417A1 Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof
05/27/2010WO2010058353A1 Novel bis-amides as antimalarial agents
05/27/2010WO2010058032A2 New compounds
05/27/2010WO2010057899A1 Cycloalkyl amino carbonyl derivatives as bradykinin-b1 receptor antagonists
05/27/2010WO2010057880A1 Novel herbicides
05/27/2010WO2010038081A3 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors
05/27/2010WO2010026110A3 6-substituted benzoxazines as 5-ht-5a receptor antagonists
05/27/2010WO2010013222A8 Pyrrole carboxylic acid derivatives as antibacterial agents
05/27/2010WO2009001192A3 Novel compounds and their use
05/27/2010US20100130736 Methods of creating an index
05/27/2010US20100130559 Novel phenyl-isoxazol-3-ol derivative
05/27/2010US20100130555 Compositions and methods for treating or preventing hypoxic or ischemic injury
05/27/2010US20100130496 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
05/27/2010US20100130495 Compounds 563
05/27/2010US20100130494 Dermatitis treating agent (as amended)
05/27/2010US20100130486 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/27/2010US20100130476 Compounds that induce pancreatic beta-cell expansion
05/27/2010US20100130473 Compounds
05/27/2010US20100130468 Indole carboxamides as ikk2 inhibitors
05/27/2010US20100130466 Triazolyl aminopyrimidine compounds
05/27/2010US20100130465 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
05/27/2010US20100130447 Inhibitors of kinase activity
05/27/2010US20100130446 Nitrogen-containing five-membered heterocyclic compound
05/27/2010US20100127616 Compound for organic electroluminescent device and organic electroluminescent device
05/27/2010CA2744351A1 New compounds
05/27/2010CA2744016A1 Treatment of amyotrophic lateral sclerosis
05/27/2010CA2743971A1 Novel antimicrobials
05/27/2010CA2743723A1 Inhibitors of diacylglycerol acyltransferase
05/27/2010CA2743609A1 Inhibitors of diacylglycerol acyltransferase
05/27/2010CA2743497A1 Inhibitors of diacylglycerol acyltransferase